Entering text into the input field will update the search result below

Merck KGaA teams up with Iktos in drug discovery

Mar. 14, 2019 9:31 AM ETMerck KGaA ADR (MKGAY) StockBy: Douglas W. House, SA News Editor
  • Merck KGaA (OTCPK:MKGAY) will collaborate with French outfit Iktos, leveraging the latter's generative modeling artificial intelligence (AI) technology in drug discovery and design.
  • According the Iktos, its AI technology enables a more rapid and efficient drug discovery process by automating the design of virtual molecules with the desired attributes for treating a given disease.
  • Financial terms are not disclosed.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
MKGAY--
Merck KGaA ADR